Business Description
Nautilus Biotechnology Inc
NAICS : 541714
SIC : 2834
ISIN : US63909J1088
Share Class Description:
NAUT: Ordinary SharesDescription
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.39 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | -0.46 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -73.5 | |||||
| 3-Year EPS without NRI Growth Rate | -59.4 | |||||
| 3-Year FCF Growth Rate | -53.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.26 | |||||
| 9-Day RSI | 59.88 | |||||
| 14-Day RSI | 56.18 | |||||
| 6-1 Month Momentum % | 3.29 | |||||
| 12-1 Month Momentum % | 13.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 20.09 | |||||
| Quick Ratio | 20.09 | |||||
| Cash Ratio | 19.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.3 | |||||
| Shareholder Yield % | -0.99 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -24.34 | |||||
| ROA % | -21.22 | |||||
| ROIC % | -54.3 | |||||
| ROC (Joel Greenblatt) % | -210.34 | |||||
| ROCE % | -25.77 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.42 | |||||
| Price-to-Tangible-Book | 1.4 | |||||
| EV-to-EBIT | -2.58 | |||||
| EV-to-EBITDA | -2.79 | |||||
| EV-to-FCF | -3.55 | |||||
| Price-to-Net-Current-Asset-Value | 2.38 | |||||
| Price-to-Net-Cash | 2.44 | |||||
| Earnings Yield (Greenblatt) % | -38.76 | |||||
| FCF Yield % | -16.38 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NAUT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nautilus Biotechnology Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.55 | ||
| Beta | 0 | ||
| Volatility % | 51.3 | ||
| 14-Day RSI | 56.18 | ||
| 14-Day ATR ($) | 0.198946 | ||
| 20-Day SMA ($) | 2.543 | ||
| 12-1 Month Momentum % | 13.14 | ||
| 52-Week Range ($) | 2.2738 - 4.65 | ||
| Shares Outstanding (Mil) | 125.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nautilus Biotechnology Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nautilus Biotechnology Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nautilus Biotechnology Inc Frequently Asked Questions
What is Nautilus Biotechnology Inc(NAUT)'s stock price today?
The current price of NAUT is $2.78. The 52 week high of NAUT is $4.65 and 52 week low is $2.27.
When is next earnings date of Nautilus Biotechnology Inc(NAUT)?
The next earnings date of Nautilus Biotechnology Inc(NAUT) is 2024-08-02 Est..
Does Nautilus Biotechnology Inc(NAUT) pay dividends? If so, how much?
Nautilus Biotechnology Inc(NAUT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers